FDA and Manufacturers Intensify Concerns about Data Integrity

被引：0
作者：
Wechsler, Jill
机构：
来源：
BIOPHARM INTERNATIONAL | 2016年 / 29卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [21] Pharmaceutical Data Integrity: issues, challenges and proposed solutions for manufacturers and inspectors
    Hock, Sia Chong
    Tay, Vernon
    Sachdeva, Vimal
    Wah, Chan Lai
    [J]. GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2020, 9 (04): : 171 - 182
  • [22] Combining efficiency and concerns about integrity when using human biobanks
    Hansson, Mats G.
    [J]. STUDIES IN HISTORY AND PHILOSOPHY OF SCIENCE PART C-STUDIES IN HISTORY AND PHILOSOPHY OF BIOLOGICAL AND BIOMEDIAL SCIENCES, 2006, 37 (03): : 520 - 532
  • [23] US FDA has concerns about safety of compounded ketamine nasal spray
    [J]. Reactions Weekly, 2022, 1895 (1) : 3 - 3
  • [24] FDA Releases Guidance on Biosimilars, Therapeutic Proteins, and Data Integrity
    不详
    [J]. BIOPHARM INTERNATIONAL, 2016, 29 (05) : 8 - 8
  • [25] What's New with the FDA's Data Integrity Guidance?
    McDowall, R. D.
    [J]. SPECTROSCOPY, 2016, 31 (09) : 22 - 29
  • [26] Concerns about modelling of the EDGES data Reply
    Bowman, Judd D.
    Rogers, Alan E. E.
    Monsalve, Raul A.
    Mozdzen, Thomas J.
    Mahesh, Nivedita
    [J]. NATURE, 2018, 564 (7736) : E35 - E35
  • [27] MANUFACTURERS VIEW OF PRODUCT INTEGRITY
    GADSDEN, HW
    [J]. FOOD DRUG COSMETIC LAW JOURNAL, 1972, 27 (01): : 34 - 39
  • [28] Concerns about pathology expertise and data quality
    McInnes, Elizabeth F.
    Meyerholz, David K.
    Arends, Mark J.
    [J]. JOURNAL OF PATHOLOGY, 2023, 259 (04) : 468 - 468
  • [29] Opioid Regulation Challenges FDA and Manufacturers
    Wechsler, Jill
    [J]. BIOPHARM INTERNATIONAL, 2013, 26 (12) : 12 - 13
  • [30] FDA and Manufacturers Ponder Biosimilars Pathway
    Wechsler, Jill
    [J]. BIOPHARM INTERNATIONAL, 2011, 24 (07) : 12 - 14
12345